Scientific Posters & Presentations

WCA (World Congress of Audiology) – September 2024

• Replay of the symposium “Are we at the Dawn of a Hearing Loss Revolution?“

IEB (Inner Ear Biology Workshop) – September 2024

• Poster – Multiplexed TMT-based quantitative proteomics identified essential players involved in the mechanism of action of SENS-401 observed under normal or ototoxic conditions in intact cochlear organ cultures

ARO (Association for Research in Otolaryngology) – January 2024

• Poster Su56 – Preclinical Development of SENS-501 as a Treatment for the Autosomal Recessive Non-Syndromic Deafness 9 (DFNB9) Using an Adeno Associated Vector-Based Gene Therapy”
• Poster S61 – Early Players Involved in Both Cisplatin-Induced Ototoxicity and SENS-401 Protection in Intact Organ Cultures” 

KOL webinar on POC Phase 2a study of SENS-401 to prevent residual hearing loss after cochlear implantation – July 5, 2023

• KOL Webinar Presentation Deck (powerpoint)
• KOL Webinar Replay

ASGCT American Society of Gene & Cell Therapy – 2023

• An Integrated Adeno-Associated Vector Development Platform for Inner Ear Disorders
• Preclinical development of an Adeno Associated Vector-Based Gene Therapy (SENS-501) for the Autosomal Recessive Non-Syndromic Deafness 9 (DFNB9)

Sensorion Gene Therapy R&D Day, April 6, 2023
Hearing Institute (Institut Pasteur)

• R&D Day Presentation Deck (Powerpoint)
• R&D Day Replay